Interleukin-4 induces mouse cytomegalovirus interstitial pneumonia in a latent infection model

J Yonemitsu1

  • 1Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan. junko@med.kurume-u.ac.jp

Insights

Interleukin-4 (IL-4) can trigger cytomegalovirus pneumonia in mice with latent mouse cytomegalovirus (MCMV) infection. This study establishes a model for MCMV-induced interstitial pneumonia, highlighting IL-4

Area of Science:

  • Immunology
  • Virology
  • Pathology

Background:

  • Understanding immune mechanisms in cytomegalovirus pneumonia is crucial.
  • Mouse cytomegalovirus (MCMV) is a model pathogen for studying viral infections.
  • Latent and persistent viral infections can have significant health implications.

Purpose of the Study:

  • To investigate immune responses during mouse cytomegalovirus (MCMV) infection.
  • To establish a murine model for MCMV-induced interstitial pneumonia.
  • To identify key cytokines involved in the pathogenesis of MCMV pneumonia.

Main Methods:

  • Intranasal inoculation of a low-virulence MCMV strain in nude and BALB/c mice.
  • Detection of MCMV replication in salivary glands using plaque assays and MCMV-DNA.
  • Treatment of latently infected BALB/c mice with methylprednisolone (m-PSL) or Interleukin-4 (IL-4) to induce pneumonia.

Main Results:

  • MCMV replicated in salivary glands of both mouse strains, with earlier detection in nude mice.
  • Latent MCMV infection was established in BALB/c mice, and persistent infection in nude mice.
  • IL-4 treatment induced interstitial pneumonia in latently infected BALB/c mice, while m-PSL did not.

Conclusions:

  • A murine model for MCMV latent infection and subsequent interstitial pneumonia was successfully developed.
  • Interleukin-4 (IL-4) is identified as a critical cytokine in the onset of interstitial pneumonia during latent MCMV infection.
  • These findings provide insights into the immune-mediated pathogenesis of cytomegalovirus pneumonia.